A detailed history of First Manhattan CO transactions in Organon & Co. stock. As of the latest transaction made, First Manhattan CO holds 23,475 shares of OGN stock, worth $358,698. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,475
Previous 24,951 5.92%
Holding current value
$358,698
Previous $516,000 12.98%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$18.65 - $23.03 $27,527 - $33,992
-1,476 Reduced 5.92%
23,475 $449,000
Q2 2024

Aug 13, 2024

SELL
$17.45 - $21.96 $544,213 - $684,866
-31,187 Reduced 55.55%
24,951 $516,000
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $73,860 - $100,768
-5,360 Reduced 8.72%
56,138 $1.06 Million
Q4 2023

Feb 13, 2024

SELL
$10.95 - $17.32 $1.88 Million - $2.98 Million
-172,090 Reduced 73.67%
61,498 $886,000
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $294,522 - $421,988
-17,753 Reduced 7.06%
233,588 $4.06 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $4.22 Million - $5.39 Million
219,021 Added 677.66%
251,341 $5.23 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $426,215 - $638,327
19,898 Added 160.18%
32,320 $760,000
Q4 2022

Feb 14, 2023

SELL
$23.31 - $28.61 $8,811 - $10,814
-378 Reduced 2.95%
12,422 $347,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $11,770 - $17,227
-503 Reduced 3.78%
12,800 $299,000
Q2 2022

Aug 15, 2022

SELL
$31.66 - $38.9 $8,231 - $10,114
-260 Reduced 1.92%
13,303 $449,000
Q1 2022

May 16, 2022

SELL
$30.45 - $39.36 $5,328 - $6,888
-175 Reduced 1.27%
13,563 $473,000
Q4 2021

Feb 14, 2022

SELL
$28.67 - $37.13 $9,375 - $12,141
-327 Reduced 2.32%
13,738 $418,000
Q3 2021

Nov 15, 2021

SELL
$28.63 - $35.64 $36,216 - $45,084
-1,265 Reduced 8.25%
14,065 $461,000
Q2 2021

Aug 16, 2021

BUY
$28.45 - $38.0 $436,138 - $582,540
15,330 New
15,330 $463,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track First Manhattan CO Portfolio

Follow First Manhattan CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.